Administration of MALAT1 siRNAand/or ASC-J9 (5-hydroxy-1,7- bis(3,4-dimethoxyphenyl)-1,4,6-heptatrien-3-one)suppressed the progression of EnzR-PCa tumor cells. This evidence concerns the gene MALAT1 and neoplasm.